GlycoEra AG

Swiss Biotech Association

Member

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.

https://glycoera.com/
+41 44 733 85 75
veronica.gambillara@glycoera.com
Veronica Gambillara Fonck

Location

Grabenstrasse 3, 8952 Schlieren, Zürich, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2020
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

Zenith Technologies

Zenith Technologies - a Cognizant Company transforms Life Sciences manufacturing with a focus on delivering speed to value. We provide scalable IT & OT end-to-end smart factory solutions, from conception through completion, across the manufacturing lifecycle.
4500 Solothurn

Member

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
6850 Mendrisio

Member

Quercis Pharma AG

Quercis Pharma AG is a private Swiss biotech company advancing a novel antithrombotic in multiple indications: the lead program is prevention of Venous Thrombosis Embolism in advanced cancer patients (phase III) followed by clinical trials in Sickle Cell Disease (phase II) and Covid-19 (phase II).
6300 Zug

Member